 Factor Xa Inhibitors
"Factor Xa Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous factors and drugs that inhibit or block the activity of FACTOR XA.
| Descriptor ID |
D065427
|
| MeSH Number(s) |
D27.505.519.389.745.800.449.500 D27.505.954.502.119.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Factor Xa Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Factor Xa Inhibitors".
This graph shows the total number of publications written about "Factor Xa Inhibitors" by people in this website by year, and whether "Factor Xa Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2017 | 1 | 1 | 2 | | 2019 | 3 | 0 | 3 | | 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Factor Xa Inhibitors" by people in Profiles.
-
Panos NG, Cook AM, John S, Jones GM. Factor Xa Inhibitor-Related Intracranial Hemorrhage: Results From a Multicenter, Observational Cohort Receiving Prothrombin Complex Concentrates. Circulation. 2020 05 26; 141(21):1681-1689.
-
Rodier SG, Kim M, Moore S, Frangos SG, Tandon M, Klein MJ, Berry CD, Huang PP, DiMaggio CJ, Bukur M. Early Anti-Xa Assay-Guided Low Molecular Weight Heparin Chemoprophylaxis Is Safe in Adult Patients with Acute Traumatic Brain Injury. Am Surg. 2020 Apr 01; 86(4):369-376.
-
Rodier SG, Bukur M, Moore S, Frangos SG, Tandon M, DiMaggio CJ, Ayoung-Chee P, Marshall GT. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting. Eur J Trauma Emerg Surg. 2021 Feb; 47(1):145-151.
-
Feldman DN, Wang TY, Chen AY, Swaminathan RV, Kim LK, Wong SC, Minutello RM, Bergman G, Singh HS, Madias C. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry. J Am Heart Assoc. 2019 04 16; 8(8):e011606.
-
Yang M, Li J, Sun R, Wang Y, Xu H, Yang B, Wu X, Yu L. Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis. J Cancer Res Ther. 2019; 15(7):1541-1546.
-
Ramesh AK, Young AC. Incidence of Clinically Overt Hematoma Formation Following Removal of Adductor Canal Catheters During Concomitant Factor Xa Inhibitor Therapy. Reg Anesth Pain Med. 2017 Nov/Dec; 42(6):798-799.
-
Mangla A, Kalra DK. Membranous ventricular septum aneurysm, differentiated from sinus of valsalva aneurysm using cardiac CT. J Cardiovasc Comput Tomogr. 2018 Jan - Feb; 12(1):92-94.
-
Carroll VS, Frei J. Oral Anticoagulants: The Move Beyond Warfarin. J Neurosci Nurs. 2016 Jul-Aug; 48(4):177.
-
Somberg JC. The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients. Am J Ther. 2011 Nov; 18(6):510-7.
-
Kereiakes DJ, Tcheng J, Fry ET, Bhatt DL, Bosker G, Diez JG, Ferguson JJ, Levine GN, Schaer GL, Zidar J. Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|